Published in Hospital Business Week, June 17th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Baxter Healthcare Corporation.
Report 1: Baxter Healthcare Corporation announced the launch of a unique Phase II clinical trial to determine if adding peritoneal ultrafiltration treatments using its proprietary icodextrin solution to the current standard Congestive Heart Failure (CHF) therapy regimen will improve clinical outcomes and reduce the amount of time patients spend in the hospital.
CHF is a serious heart condition in which blood flow slows and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.